Products

Products

Prognostic & predictive Test for Liver cancer

A prognostic and predictive combined test to predict the 5-year survival as well as the efficacy of treatment for liver cancer patients. The test can
- Significantly reduce the expense of diagnostic test by one-stop service
- Support the determination of treatment (surgery / Nexevar®)
The service is expected to be launched in the second half of 2020.

  • 1 The Ministry of Health and Welfare certified (Notice 2010-83)
  • 2 CbsBio AI platform technology applied on the development of prognostic test
  • 3 The world’s first prognostic tests to predict survival of liver cancer
  • 4 Nexavar® CDx test development